News & Analysis » US
Cell Therapeutics Closes F Sale Of $4.06 Mln Of Securities In Private Offering - Quick Facts
(RTTNews) - Tuesday, Cell Therapeutics Inc. (CTIC) closed its previously announced sale of $4.06 million of securities to an accredited investor in a private offering. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock
Prior to the closing date, the investor elected to convert all of its shares of Series 6 preferred stock and to receive the 11.6 million shares of the Company's common stock issuable upon such conversion at the closing. Rodman & Renshaw, LLC, a wholly-owned subsidiary of Rodman & Renshaw Capital Group, Inc., acted as the exclusive placement agent for the offering.
CITC closed Tuesday's trading at $0.39, down $0.0028 on a volume of 8 million shares on the Nasdaq.
Stock Market Forum
- how do you find canada stocks to trade?
3 February 2012
- my stock to watch for tomorrow-CLD
3 February 2012
- Dynamic levels is all about showing the stock levels for last 12 years.
19 January 2012
- Bank of England Keeps Base Rate unaffected at 0.50%
13 January 2012
- Oil price rise fuels India's inflation
4 January 2012
- How to invest in stock market
27 December 2011
- Four Secrets to invest in Stock Market: Beginners Guide
27 December 2011
- Food inflation plunges to 4-year low of 1.81%
22 December 2011
- Nifty delete certain posts gains on GDP data
22 December 2011
- Big Ben's Investing
22 December 2011